Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy OptiNose stock (OPTN)

Buy OptiNose stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

OptiNose is a drug manufacturers - specialty & generic business based in the US. OptiNose shares (OPTN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.54 – an increase of 0.43% over the previous week. OptiNose employs 132 staff and has a trailing 12-month revenue of around $75.7 million.

Our top picks for where to buy OptiNose stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, and options with as little as $1
  • After-hours trading available
  • Earn 4.5% interest on uninvested cash with Gold
  • 24/7 customer support

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Complimentary access to a financial planner

How to buy OptiNose stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – OPTN. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy OptiNose stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO
Finder Score: 3.8 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Robinhood
Finder Score: 4.6 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
SoFi Invest®
Finder Score: 4.3 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
Uphold
Finder Score: 3.6 / 5: ★★★★★
Crypto alternative
Uphold
★★★★★
Cryptocurrency
N/A
$0
4.65%
Get $10
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Public.com
Finder Score: 4.4 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

OptiNose stock price (NASDAQ: OPTN)

Use our graph to track the performance of OPTN stocks over time.

OptiNose shares at a glance

Information last updated 2024-11-27.
Latest market close$0.54
52-week range$0.32 - $2.10
50-day moving average $0.67
200-day moving average $1.06
Wall St. target price$3.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.29

Is it a good time to buy OptiNose stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OptiNose price performance over time

Historical closes compared with the close of $0.5001 from 2024-11-29

1 week (2024-11-27) -6.65%
1 month (2024-11-04) -25.35%
3 months (2024-09-04) -49.55%
6 months (2024-06-04) -53.26%
1 year (2023-12-04) -65.75%
2 years (2022-12-02) -71.42%
3 years (2021-12-03) 1.56
5 years (2019-12-04) 8.91

OptiNose financials

Revenue TTM $75.7 million
Gross profit TTM $67 million
Return on assets TTM -10.32%
Return on equity TTM -1050.5%
Profit margin -41.16%
Book value $-0.24
Market Capitalization $80.8 million

TTM: trailing 12 months

OptiNose share dividends

We're not expecting OptiNose to pay a dividend over the next 12 months.

OptiNose share price volatility

Over the last 12 months, OptiNose's shares have ranged in value from as little as $0.321 up to $2.1. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OptiNose's is -0.068. This would suggest that OptiNose's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, OptiNose has bucked the trend.

OptiNose overview

OptiNose, Inc. , a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania. .

Frequently asked questions

What percentage of OptiNose is owned by insiders or institutions?
Currently 5.983% of OptiNose shares are held by insiders and 78.469% by institutions.
How many people work for OptiNose?
Latest data suggests 132 work at OptiNose.
When does the fiscal year end for OptiNose?
OptiNose's fiscal year ends in December.
Where is OptiNose based?
OptiNose's address is: 1020 Stony Hill Road, Yardley, PA, United States, 19067
What is OptiNose's ISIN number?
OptiNose's international securities identification number is: US68404V1008
What is OptiNose's CUSIP number?
OptiNose's Committee on Uniform Securities Identification Procedures number is: 68404V100

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site